SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 32 filers reported holding OCUPHIRE PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q3 2022$30,000
-64.3%
15,105
-42.0%
0.00%
-50.0%
Q1 2022$84,000
-14.3%
26,055
-0.7%
0.00%
-33.3%
Q4 2021$98,0000.0%26,246
+37.8%
0.00%
+50.0%
Q3 2021$98,000
+12.6%
19,041
+15.8%
0.00%0.0%
Q2 2021$87,00016,4410.00%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Regency Capital Management Inc.\DE 15,000$79,0000.06%
Ikarian Capital, LLC 119,551$632,0000.05%
NORRIS PERNE & FRENCH LLP/MI 78,909$417,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 23,445$124,0000.02%
Stokes Family Office, LLC 12,120$64,0000.01%
MARSHALL WACE, LLP 329,131$1,738,0000.01%
Cornerstone Capital, Inc. 11,357$60,0000.01%
MCF Advisors LLC 9,499$50,0000.01%
Cutler Group LLC / CA 7,900$41,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 13,389$71,0000.00%
View complete list of OCUPHIRE PHARMA INC shareholders